Cargando…
Anti-COVID-19 activity of some benzofused 1,2,3-triazolesulfonamide hybrids using in silico and in vitro analyses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic fatal infection with no known treatment. The severity of the disease and the fast viral mutations forced the scientific community to search for potential solution. Here in the present manuscript, some benzofused1,2,3triazoles...
Autores principales: | Alzahrani, Abdullah Y., Shaaban, Marwa M., Elwakil, Bassma H., Hamed, Moaaz T., Rezki, Nadjet, Aouad, Mohamed R., Zakaria, Mohamed A., Hagar, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434689/ https://www.ncbi.nlm.nih.gov/pubmed/34538993 http://dx.doi.org/10.1016/j.chemolab.2021.104421 |
Ejemplares similares
-
1,2,3-Triazole-Benzofused Molecular Conjugates as Potential Antiviral Agents against SARS-CoV-2 Virus Variants
por: Al-Humaidi, Jehan Y., et al.
Publicado: (2022) -
Novel 1,2,3-Triazole-sulphadiazine-ZnO Hybrids as Potent Antimicrobial Agents against Carbapenem Resistant Bacteria
por: Aljohani, Faizah S., et al.
Publicado: (2022) -
Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study
por: Arafa, Fadwa M., et al.
Publicado: (2023) -
Exploring the Antiparasitic Activity of Tris-1,3,4-Thiadiazoles against Toxoplasma gondii-Infected Mice
por: Almutairi, Tahani M., et al.
Publicado: (2022) -
Synthesis, Characterization and Nanoformulation of Novel Sulfonamide-1,2,3-triazole Molecular Conjugates as Potent Antiparasitic Agents
por: Aljohani, Faizah S., et al.
Publicado: (2022)